Revisiting the role of fat mass in the life extension induced by caloric restriction

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 3, 1999, Pages

  Barzilai, Nir ^a   Gupta, Gaurav ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; LEPTIN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BODY FAT; CALORIC RESTRICTION; CONTROLLED STUDY; EXERCISE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR;

ANIMALIA; RODENTIA;

EID: 0033039097     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.3.b89     Document Type: Article

References (110)

1. Ross M, Bras G. Food preference and length of life. Science. 1975;190: 165-167.
2. Young VR. Diet as a modulator of aging and longevity. [Review]. Fed Proc. 1979; 38:1994-2000.
3. Masoro E, Yu B, Bertrand H, Lynd F. Nutritional probe of the aging process. Fed Proc. 1980; 39:3178-3182.
4. Johnson BC, Good RA. Chronic dietary restriction and longevity. Proc Soc Exp Biol Med. 1990;193:4-5.
5. Leis HPJ. The relationship of diet to cancer, cardiovascular disease and longevity. Int Surg. 1991;76:1-5.
6. Sprott R. Diet and calorie restriction. Exp Gerontol. 1997;32:205-214.
7. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest. 1998;101:1353-1361.
8. Holloszy JO. Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. J Appl Physiol. 1997;82:399-403.
9. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, Goodyear LJ. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest. 1997;99:1251-1257.
10. Paffenbarger RSJ, Hyde RT, Wing AL, Lee M, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538-545.
11. Abe T, Kawakami Y, Sugita M, Fukunaga T. Relationship between training frequency and subcutaneous and visceral fat in women. Med Sci Sports Exerc. 1997;29:1549-1553.
12. Stuchlikova E, Juricova-Horakova M, Deyl Z. New aspects of the dietary effect of life prolongation in rodents. What is the role of obesity in aging? Exp Gerontol. 1975;10:141-144.
13. Bertrand HA, Lynd FT, Masoro EJ, Byung PY. Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging diet. J Gerontol. 1980;35:827-835.
14. Harrison D, Archer J, Astle C. Effects of food restriction on aging: separation of food intake and adiposity. Proc Natl Acad Sci USA. 1984;81: 1835-1838.
15. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-549.
16. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543-546.
17. Randle PJ, Garland PB, Hales CN, Newsholmes EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;I:785-789.
18. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of free fatty acids on glucose production and utilization in man. J Clin Invest. 1983;72:1737-1747.
19. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen E. Effects of fat on insulin-mediated carbohydrate metabolism in normal men. J Clin Invest. 1991;88:960-966.
20. Groop L, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest. 1991;87:83-89.
21. Oscai L, Holloszy J. Weight reduction in obese rats by exercise or food restriction: effect on the heart. Am J Physiol. 1970;219:327-330.
22. Young J, Mullen D, Landsberg L. Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism. 1978;27:1711-1714.
23. Liepa GU, Masoro EJ, Bertrand HA, Yu BP. Food restriction as a modulator of age-related changes in serum lipids. Am J Physiol. 1980;238: E253-E257.
24. Safai-Kutti S, Fernandes G, Wang Y, Safai B, Good RA, Day NK. Reduction of circulating immune complexes by calorie restriction in (NZB X NZW) Fl mice. Clin Immunol Immunopathol. 1980;15: 293-300.
25. Levin P, Janda JK, Joseph JA, Ingram DK, Roth GS. Dietary restriction retards the age-associated loss of rat striatal dopaminergic receptors. Science. 1981;214:561-562.
26. Jung LK, Palladino MA, Galvano S, Mark DA, Good RA, Fernandes G. Effect of calorie restriction on the production and responsiveness to interleukin 2 in (NZB X NZW)F1 mice. Clin Immunol Immunopathol. 1982; 25:295-301.
27. McCarter RJ, Masoro EJ, Yu BP. Rat muscle structure and metabolism in relation to age and food intake. Am J Physiol. 1982;242:R89-R93.
28. Kalu DN, Hardin RR, Cockerham R, Yu BP, Norling BK, Egan JW. Lifelong food restriction prevents senile osteopenia and hyperparathyroidism in F344 rats. Mech Ageing Dev. 1984;26:103-112.
29. Leveille PJ, Weindruch R, Walford RL, Bok D, Horwitz J. Dietary restriction retards age-related loss of gamma crystallins in the mouse lens. Science. 1984 224:1247-1249.
30. Pollard M, Lucker PH, Pan GY. Inhibition of intestinal tumorigenesis in methylazoxymethanoltreated rats by dietary restriction. Cancer Treatment Rep. 1984;68:405-408.
31. Holehan AM, Merry BJ. The control of puberty in the dietary restricted female rat. Mech Ageing Dev. 1985;32:179-191.
32. Ingram DK, Weindruch R, Spangler EL, Freeman JR, Walford RL. Dietary restriction benefits learning and motor performance of aged mice. J Gerontol. 1987;42:78-81.
33. Holliday R. Food, reproduction and longevity: is the extended lifespan of calorie-restricted animals an evolutionary adaptation? Bioessays. 1989;10:125-127.
34. Masoro E, Iwasaki K, Gleiser C, McMahan C, Seo E, Yu B. Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr. 1989;49:1217-1227.
35. Masoro E, Katz M, McMahan C. Evidence for the glycation hypothesis of aging from the foodrestricted rodent model. J Gerontol Biol Sci. 1989; 44:B20-B22.
36. Katzeff H, Yang M, Presta E, Leibel R, Hirsch J, Van Itallie T. Calorie restriction and iopanoic acid effects on thyroid hormone metabolism. Am J Clin Nutr. 1990;52:263-266.
37. Sabatino F, Masoro E, McMahan C, Kuhn R. Assessment of the role of the glucocorticoid system in aging processes and in the action of food restriction. J Gerontol Biol Sci. 1991;46:B171-B179.
38. Masoro E, McCarter R, Katz M, McMahan C. Dietary restriction alters characteristics of glucose fuel use. J Gerontol Bio Sci. 1992;47:B202-B208.
39. Thurman JD, Bucci TJ, Hart RW, Turturro A. Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats. Toxicol Pathol. 1994;22:1-9.
40. Higami Y, Yu B, Shimokawa I, Bertrand H, Hubbard G, Masoro Ex. Anti-tumor action of dietary restriction is lesion-dependent in male Fischer 344 rats. J Gerontol A Biol Sci. 1995;50:B72-B77.
41. Despres J, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334: 952-957.
42. Casirola DM, Lan Y, Ferraris RP. Effects of changes in calorie intake on intestinal nutrient uptake and transporter mRNA levels in aged mice. J Gerontol A Biol Sci. 1997;52:B300-B310.
43. Taffet GE, Pham TT, Hartley CJ. The age-associated alterations in late diastolic function in mice are improved by caloric restriction. J Gerontol A Biol Sci. 1997;52:B285-B290.
44. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997;46:860-867.
45. Cortellaro M, Cofrancesco E, Boschetti C, et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arterioxcler Thromb. 1993;13:1412-1417.
46. Calles-Escandon J, Ballor D, Harvey-Berino J, Ades P, Tracy R, Sobel B. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction. Am J Clin Nutr. 1996 64:7-11.
47. Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin expression in genetic and acquired obesity. Science. 1987;237:405-408.
48. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol. 1988;107:1269-1277.
49. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet. 1989;1:1122-1126.
50. White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992 267:9210-9213.
51. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr. 1997;127:1014S-1016S.
52. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to Clq, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746-26749.
53. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
54. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
55. Bogardus C, Lillia S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol. 1985;248:E286-E291.
56. Reaven GM. Role of insulin resistance in human disease (Banting lecture). Diabetes. 1988;37:1595-1607.
57. Barzilai N, Rossetti L. The relationship between changes in body composition and insulin responsiveness in models of aging rats. Am J Physiol. 1995;269:E591-E597.
58. Banerjee S, Saenger P, Hu M, Chen W, Barzilai N. Fat accretion and the regulation of insulin-mediated glycogen synthesis following puberty in rats. Am. J. Physiol. 1997;273:R1534-R1539.
59. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. EGIR (European Group for Insulin Research). Insulin action and age. Diabetes. 1996;45:947-953.
60. Cerami A. Hypothesis. Glucose as a mediator of aging. J Am Geriatr Soc. 1985;33:626-634.
61. Mlekusch W, Lamprecht M, Ottl K, Tillian M, Reibnegger G. A glucose-rich diet shortens longevity of mice. Mech Ageing Dev. 1996;92:43-51.
62. Parr T. Insulin exposure and aging theory. Gerontology. 1997;43: 182-200.
63. Kimura K, Tissenbaum H, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997;277:942-946.
64. Feinstein R, Kanety H, Papa MS, Lunenfeld B, Karasic A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055-26057.
65. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94:1543-1549.
66. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem. 1995;270:23780-23784.
67. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665-668.
68. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem. 1997;272:971-976.
69. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997;389:610-614.
70. Ventre J, Doebber T, Wu M, et al. Targeted disruption of the tumor necrosis factor-alpha geneimetabolic consequences in obese and nonobese mice. Diabetes. 1997;46:1526-1531.
71. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
72. Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci USA. 1997;94:4242-4245.
73. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:324-325.
74. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540-543.
75. Mantzoros CS, Moschos S, Avramopoulos I, et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab. 1997;82:3408-3413.
76. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996;81:3419-3423.
77. Ahren B, Mansson S, Gingerich R, Havel P. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol. 1997;273:R113-R120.
78. Masoro E. Glucocorticoids and aging. Aging. 1995;7:407-413.
79. Ahima R, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-252.
80. Licinio J, Mantzoros C, et al. Human leptin levels are pulsatile and inversely related to pituitaryadrenal function. Nature Med. 1997;3: 575-579.
81. Cahill GJ, Herrera M, Morgan A, et al. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966;45:1751-1769.
82. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 1997;138:2569-2576.
83. Ahima R, Dushay J, Flier S, Prabakaran D, Flier J. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest. 1997;99:391-395.
84. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab. 1997;82:1066-1070.
85. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998;393:684-688.
86. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest. 1997;100:2777-2782.
87. Parr T. Insulin exposure and aging theory. Gerontology. 1997;43:182-200.
88. Barzilai N, Banerjee S, Hawkins M, Chang C-J, Chen W, Rossetti L. The effect of age-dependent increase in fat mass on peripheral insulin action is saturable. J Gerontol A Biol Sci. 1998;53:B141-B146.
89. Rissanen A, Heliovaara M, Knekt P, Aromaa A, Reunanen A, Maatela J. Weight and mortality in Finnish men. J Clin Epidemiol. 1989;42: 781-789.
90. Rissanen A, Knekt P, Heliovaara M, Aromaa A, Reunanen A, Maatela J. Weight and mortality in Finnish women. J Clin Epidemiol. 1991;44:787-795.
91. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
92. Lindsted KD, Singh PN. Body mass and 26-year risk of mortality among women who never smoked: findings from the Adventist Mortality Study. Am J Epidemiol. 1997;146:1-11.
93. Folsom AR KS, Sellers TA, Hong CP, Cerhan JR, Potter JD. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269: 483-487.
94. Borkan GA, Hults DE, Gerzof SG, Robbins AH, Silbert CK. Age changes in body composition revealed by computed tomography. J Gerontol. 1983;38:673-677.
95. Enzi G, Gasparo M, Binodetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr. 1986;44:739-746.
96. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R. Studies in the distribution of body fat: 1. Effects of age sex, and obesity. J Gerontol Med Sci. 1989;44:M66-M73.
97. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab. 1988;67:760-767.
98. Colberg SR, Simoneau JA, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with with visceral obesity. J Clin Invest. 1995;95:1427-1428.
99. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633-638.
100. Coon PJ, Rogus EM, Drinkwater D, Muller DC, Goldberg AP. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab. 1992;75:1125-1132.
101. Larson B. Regional obesity as a health hazard in men-prospective studies. Acta Med Scan. 1992;723:45-51.
102. Prineas R, Folsom A, Kaye S. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol. 1993;11:35-41.
103. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med. 1996;2:800-803.
104. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997;46:342-347.
105. Stiles J, Francendese A, Masoro E. Influence of age on size and number of fat cells in the epididymal depot. Am J Physiol. 1975;229:1561-1568.
106. Barzilai N, Rossetti L. Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am J Physiol. 1996;270:E930-E936.
107. Williamson J, Kreisberg RA, Pelts PW. Mechanisms for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA. 1966 56:247-254.
108. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132-1143.
109. Barzilai N, Wang J, Massilon D, Vuguin P, Hawhins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest. 1997;100:3105-3110.
110. Barzilai N, She L, Liu B-Q, Hu M, Rossetti L. Surgical removal of visceral fat in rats reverses hepatic insulin resistance. Diabetes. 1999;48: 94-98.